- 𝓑𝓾𝓲𝓵𝓭𝓲𝓷𝓰 𝓕𝓾𝓽𝓾𝓻𝓮 & 𝓦𝓮𝓪𝓵𝓽𝓱 𝓣𝓸𝓰𝓮𝓽𝓱𝓮𝓻 –
More than 30% IRR per annum on investments in pre-IPO Neuralink
We invite you to invest with us into a leading developer developing brain-computer interface (BCI) technology.
Please push the button below to submit an Application and join us in one of the most interesting and profitable investment journeys ever!
Neuralink is an American company engaged in development brain-computer interfaces (BCI).

Founded in 2016 by Elon Mask. The company is developing implantable devices that can interact directly with brain, for the purpose of treatment neurological diseases and expanding human capabilities.
Please push the button below to submit an Application and join us in one of the most interesting and profitable investment journeys ever!
Why is it worth it? invest in Neuralink
In a Nutshell
$100+
billion
Growth potential
companies by 2029
billion
1+
potential consumers
in world
$5
billion
Last indicative
capitalization Neuralink
No. 1
World leader neural interfaces
for human brain
Pre-IPO investment success stories
Many companies have demonstrated impressive success stories since going public. Let's look at examples of such companies.
UiPath
The company specializes in developing a platform for robotic business processes
Palantir
Developer of data analysis software for organizations
Confluent
Infrastructure software, database management systems, integration and data quality analysis tools, analytics and BI
Gitlab
Web-based, open source DevOps lifecycle tool
Investment Rationale
1. Leadership in Brain-Computer Interface (BCI) Technology
  • Innovative Technology: Neuralink is developing advanced neural implants designed to interface directly with the human brain. These implants feature up to 1,024 channels for recording and stimulating brain activity.
  • Market Potential: The global BCI market is projected to reach $3.85 billion by 2027, with Neuralink positioned to lead due to its early entry and technological advancements.
  • Early Success: In July 2023, Neuralink demonstrated its implant technology with a pig named Gertrude, showcasing the ability to monitor brain activity in real-time.

2. Strong Financial Backing and Valuation
  • Elon Musk’s Influence: Co-founded by Elon Musk, Neuralink benefits from his reputation and investment acumen, drawing on his experience with Tesla and SpaceX.
  • Funding: Neuralink has raised over $363 million in funding rounds as of 2023, including investments from high-profile venture capital firms.
  • Valuation: The company’s valuation is estimated at $5 billion

3. Transformative Healthcare Applications
  • Medical Innovations: Neuralink’s technology aims to address neurological disorders such as paralysis, Alzheimer’s, and epilepsy by enabling direct brain-to-computer communication.
  • Restorative Potential: Future applications include potentially restoring sensory functions like vision and hearing. The neuroprosthetics market, which Neuralink could significantly impact, is expected to grow to $14.6 billion by 2026.
How to become a shareholder of Neuralink
1
2
and the manager will advise you on all questions of interest
and add Neuralink shares
to your portfolio
Leave a request
Complete the deal
Submit your application
If you have any questions or need help from a personal manager, leave your contact details and we will contact you
Your Name
Your phone
Your question
Your Email Address
Contacts
ARIZE Capital Leaders in Top U.S. Technology Companies. We provide the opportunity to invest in the TOP 20 high-tech and fast-growing companies that are not yet publicly traded, but in terms of their characteristics correspond to public companies, and therefore may go public in the near future.


Join us to build Future and Wealth Together!
CONTACT
Address: USA, California, San Francisco District, San Francisco, 24th Avenue
E-mail: info@arizecap.com
Address: USA, NY, New York,
10018, 66 West 38 Street
E-mail: info@arizecap.com
United Kingdom, London, Flagstaff House, 12, 9 St. George's Wharf, SW8 2LE
E-mail: info@arizecap.com
London
New-York
San-Fransisco